Alginic Acid
CAS 9005-32-7
Alginic Acid (CAS 9005-32-7) is a pharmaceutical compound with 0 bioactivity targets and 172 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| ALGINIC ACID | 17305 | SU | MTHSPL |
| alginic acid | 17305 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Alginic Acid used for in pharmaceutical contexts?
Alginic Acid (CAS 9005-32-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Alginic Acid?
Alginic Acid has 172 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Blister, Cataract, Pancreatitis, Visual impairment, Abdominal discomfort. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Alginic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Alginic Acid with EU status "permitted".
What clinical phase is Alginic Acid in?
No phase 1-4 clinical development badge is rendered for Alginic Acid because the matched compound identifier rows do not contain a max-phase value.